Provided by Tiger Trade Technology Pte. Ltd.

KT Corp

21.53
+0.15000.70%
Post-market: 21.50-0.0300-0.14%17:45 EDT
Volume:708.06K
Turnover:15.31M
Market Cap:10.38B
PE:8.72
High:21.81
Open:21.50
Low:21.39
Close:21.38
52wk High:24.58
52wk Low:16.25
Shares:482.00M
Float Shares:482.00M
Volume Ratio:0.47
T/O Rate:0.15%
Dividend:0.92
Dividend Rate:4.28%
EPS(TTM):2.47
EPS(LYR):2.46
ROE:9.81%
ROA:3.61%
PB:0.77
PE(LYR):8.74

Loading ...

A Look At Kymera Therapeutics (KYMR) Valuation After Late Breaking KT-621 AAD 2026 Selection

Simply Wall St.
·
Mar 22

JTEKT Corp Cuts FY Net View to Y10.00B

Dow Jones
·
Mar 19

Kintor Pharma-B Shares Surge Over 5% in Morning Session on Strategic Skincare Partnership

Stock News
·
Mar 18

CHICMAX (02145) Enters Strategic Collaboration Framework with Suzhou Kintor for KT-939

Stock News
·
Mar 17

KINTOR PHARMA-B Shares Surge Over 9% Again on Cosmetics Venture

Stock News
·
Mar 16

KINTOR PHARMA-B (09939) Enters Strategic Partnership with Funuo Pharma to Commercialize Cosmetic Ingredient KT-939

Stock News
·
Mar 12

KT Calls March 31 AGM as AICT Push Delivers Higher 2025 Earnings

TIPRANKS
·
Mar 10

South Korea-Focused ETFs Climb as Korea Composite Index Surges to Tops 6,000. Direxion Daily South Korea Bull ETF Soars 6%

Tiger Newspress
·
Feb 25

9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies

GlobeNewswire
·
Feb 24

KT FY2025 operating profit jumps 3.05x to KRW 2.47tn (YoY +205.0%)

Reuters
·
Feb 23

Samsung Electronics, KT, Keysight Verify 7GHz eMIMO Technology

MT Newswires Live
·
Feb 20

YKT Corp Sees FY Net Y170.00M

Dow Jones
·
Feb 13

KT Up Nearly 6%, on Track for Highest Close Since May 2008 -- Data Talk

Dow Jones
·
Feb 11

KT Reports Q4 Operating Income, Higher Revenue; Shares Up Pre-Bell

MT Newswires Live
·
Feb 10

KT Skylife Narrows Loss in Q4 2025

MT Newswires Live
·
Feb 09

Kymera Therapeutics: KT-621’s Differentiated Efficacy and Safety Profile Underpins Attractive Risk-Reward in Emerging Oral Atopic Dermatitis Market

TIPRANKS
·
Feb 03

JTEKT Corp 9-Mos Net Y21.35B Vs Net Y9.95B

Dow Jones
·
Feb 03

Kymera Therapeutics initiates dosing in BREADTH Phase 2b trial of KT-621

TIPRANKS
·
Jan 29

KT Corp. on Track for Highest Close Since August 2025 -- Data Talk

Dow Jones
·
Jan 28

Trump Raises Tariffs on South Korean Goods to 25%

Dow Jones
·
Jan 27